MMSI Merit Medical Systems Inc

$87.55

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 11/7/2025

About Merit Medical Systems Inc

Merit Medical Systems, Inc. manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, intensive care, and endoscopy. The company is headquartered in South Jordan, Utah.

Website: https://www.merit.com

Sector
LIFE SCIENCES
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
856982
Address
1600 WEST MERIT PARK WAY, SOUTH JORDAN, UT, US
Valuation
Market Cap
$5.37B
P/E Ratio
44.77
PEG Ratio
2.16
Price to Book
3.89
Performance
EPS
$2.03
Dividend Yield
—
Profit Margin
8.87%
ROE
9.33%
Technicals
50D MA
$101.22
200D MA
$97.87
52W High
$111.45
52W Low
$71.57
Fundamentals
Shares Outstanding
59M
Target Price
$117.82
Beta
0.85

MMSI EPS Estimates vs Actual

● Estimated
● Actual

MMSI News & Sentiment

Nov 05, 2025 • GlobeNewswire SOMEWHAT-BULLISH
Merit Medical Releases 24-Month Efficacy Results from the Randomized Arteriovenous Fistula ( AVF ) Arm of the WRAPSODY Arteriovenous Access Efficacy ( WAVE ) Trial
SOUTH JORDAN, Utah, Nov. 05, 2025 ( GLOBE NEWSWIRE ) -- Merit Medical Systems, Inc. ( NASDAQ: MMSI ) , a global leader of healthcare technology, today announced positive findings from the randomized AVF arm of the WAVE trial. These findings were presented during the Late-Breaking Clinical Trials ...
Nov 03, 2025 • GlobeNewswire SOMEWHAT-BULLISH
Merit Medical Releases 24-Month Efficacy Results from the Single-Arm Arteriovenous Graft ( AVG ) Cohort of the WRAPSODY Arteriovenous Access Efficacy ( WAVE ) Trial
SOUTH JORDAN, Utah, Nov. 03, 2025 ( GLOBE NEWSWIRE ) -- Merit Medical Systems, Inc. ( NASDAQ: MMSI ) , a global leader of healthcare technology, today announced 24-month efficacy findings from the non-randomized AVG cohort of the WAVE trial.
Oct 31, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Merit Medical Q3 Earnings & Revenues Beat Estimate, Margins Expand
MMSI beats third-quarter 2025 estimates on strong revenue and margin growth, prompting a raised full-year outlook across segments.
Oct 23, 2025 • Zacks Commentary SOMEWHAT-BULLISH
WST Stock Up on Q3 Earnings Beat, EPS View Raised on Demand & FX Benefit
West Pharmaceutical's strong Q3 beat and raised EPS outlook highlight robust demand, FX tailwinds, and solid growth in Proprietary Products.
Oct 16, 2025 • Zacks Commentary BULLISH
Here's Why Merit Medical ( MMSI ) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Oct 16, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Merit Medical Expands GI Portfolio With $22M C2 CryoBalloon Acquisition
MMSI is set to acquire C2 CryoBalloon from Pentax for $22M, strengthening its GI portfolio. Despite near-term dilution, the deal positions Merit for long-term growth in gastroenterology.
Sentiment Snapshot

Average Sentiment Score:

0.276
50 articles with scored sentiment

Overall Sentiment:

Bullish

MMSI Reported Earnings

Jul 30, 2025
Jun 30, 2025 (Pre market)
0.16 Surprise
  • Reported EPS: $1.01
  • Estimate: $0.85
  • Whisper: —
  • Surprise %: 19.2%
Apr 24, 2025
Mar 31, 2025 (Pre market)
0.11 Surprise
  • Reported EPS: $0.86
  • Estimate: $0.75
  • Whisper: —
  • Surprise %: 14.8%
Feb 25, 2025
Dec 31, 2024 (Post market)
0.1 Surprise
  • Reported EPS: $0.93
  • Estimate: $0.83
  • Whisper: —
  • Surprise %: 12.1%
Oct 30, 2024
Sep 30, 2024 (Post market)
0.06 Surprise
  • Reported EPS: $0.86
  • Estimate: $0.80
  • Whisper: —
  • Surprise %: 7.5%
Aug 01, 2024
Jun 30, 2024 (Post market)
0.05 Surprise
  • Reported EPS: $0.92
  • Estimate: $0.87
  • Whisper: —
  • Surprise %: 5.8%
Apr 30, 2024
Mar 31, 2024 (Post market)
0.06 Surprise
  • Reported EPS: $0.77
  • Estimate: $0.71
  • Whisper: —
  • Surprise %: 8.4%
Feb 28, 2024
Dec 31, 2023 (Post market)
0.04 Surprise
  • Reported EPS: $0.81
  • Estimate: $0.77
  • Whisper: —
  • Surprise %: 5.2%
Oct 26, 2023
Sep 30, 2023 (Post market)
0.1 Surprise
  • Reported EPS: $0.75
  • Estimate: $0.65
  • Whisper: —
  • Surprise %: 15.4%
Jul 25, 2023
Jun 30, 2023 (Post market)
0.06 Surprise
  • Reported EPS: $0.81
  • Estimate: $0.75
  • Whisper: —
  • Surprise %: 8.0%

Financials